Chemical Structure (Trikafta 01)
Trikafta Kit
Product Images NDC 51167-331
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Trikafta (NDC 51167-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Trikafta 02)
Chemical Structure (Trikafta 03)
Figure 1 (Trikafta 04)
Principal Display Panel (Kit Carton)
trikaftar is a medication with three active ingredients (elexacaftor, tezacaftor, and ivacaftor) available in dosages of 100mg, 50mg, and 75mg. It also has ivacaftor in 150mg tablets, each bottle containing 84 tablets. The recommended dosage should be obtained from the prescribing information. It is important to refill prescriptions 7-10 days before taking the last dose.*
Trikafta 06
This text appears to be a medication guide for Trikafta, a drug used to treat cystic fibrosis. It reminds users to refill their prescription 7-10 days before taking their last dose of the medication, and provides information on dosages and administration. The text also lists the manufacturing company and relevant product information, including the drug's active ingredients and recommended use instructions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
